206 related articles for article (PubMed ID: 28477014)
1. Anti-complement component 5 antibody targeting MG4 domain inhibits choroidal neovascularization.
Jo DH; Kim JH; Yang W; Kim H; Chang S; Kim D; Chang M; Lee K; Chung J; Kim JH
Oncotarget; 2017 Jul; 8(28):45506-45516. PubMed ID: 28477014
[TBL] [Abstract][Full Text] [Related]
2. Drusen complement components C3a and C5a promote choroidal neovascularization.
Nozaki M; Raisler BJ; Sakurai E; Sarma JV; Barnum SR; Lambris JD; Chen Y; Zhang K; Ambati BK; Baffi JZ; Ambati J
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2328-33. PubMed ID: 16452172
[TBL] [Abstract][Full Text] [Related]
3. Blockage of tissue factor ameliorates the lesion of laser-induced choroidal neovascularization in mice.
Wang L; Yang Z; Yu Y; Cui C; Guan H; Chen H
Exp Eye Res; 2014 Oct; 127():117-23. PubMed ID: 25063201
[TBL] [Abstract][Full Text] [Related]
4. Connecting the innate and adaptive immune responses in mouse choroidal neovascularization via the anaphylatoxin C5a and γδT-cells.
Coughlin B; Schnabolk G; Joseph K; Raikwar H; Kunchithapautham K; Johnson K; Moore K; Wang Y; Rohrer B
Sci Rep; 2016 Mar; 6():23794. PubMed ID: 27029558
[TBL] [Abstract][Full Text] [Related]
5. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice.
Ambati J; Anand A; Fernandez S; Sakurai E; Lynn BC; Kuziel WA; Rollins BJ; Ambati BK
Nat Med; 2003 Nov; 9(11):1390-7. PubMed ID: 14566334
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal TSG-6 suppresses laser-induced choroidal neovascularization by inhibiting CCR2+ monocyte recruitment.
Kim SJ; Lee HJ; Yun JH; Ko JH; Choi DY; Oh JY
Sci Rep; 2015 Jul; 5():11872. PubMed ID: 26149224
[TBL] [Abstract][Full Text] [Related]
7. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal inhibition of complement C5a reduces choroidal neovascularization in mice.
Brockmann C; Brockmann T; Dege S; Busch C; Kociok N; Vater A; Klussmann S; Strauß O; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1695-704. PubMed ID: 25981118
[TBL] [Abstract][Full Text] [Related]
9. Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment.
Hagbi-Levi S; Abraham M; Tiosano L; Rinsky B; Grunin M; Eizenberg O; Peled A; Chowers I
J Immunol Res; 2019; 2019():8535273. PubMed ID: 31467935
[TBL] [Abstract][Full Text] [Related]
10. Active drug targeting with immunoconjugates to choroidal neovascularization.
Yasukawa T; Kimura H; Tabata Y; Miyamoto H; Honda Y; Ikada Y; Ogura Y
Curr Eye Res; 2000 Dec; 21(6):952-61. PubMed ID: 11262619
[TBL] [Abstract][Full Text] [Related]
11. Cinidium officinale and its Bioactive Compound, Butylidenephthalide, Inhibit Laser-Induced Choroidal Neovascularization in a Rat Model.
Lee YM; Lee YR; Kim JS; Kim YH; Kim J
Molecules; 2015 Nov; 20(11):20699-708. PubMed ID: 26610445
[TBL] [Abstract][Full Text] [Related]
12. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization.
Bora PS; Sohn JH; Cruz JM; Jha P; Nishihori H; Wang Y; Kaliappan S; Kaplan HJ; Bora NS
J Immunol; 2005 Jan; 174(1):491-7. PubMed ID: 15611275
[TBL] [Abstract][Full Text] [Related]
13. Preliminary in vitro and in vivo assessment of a new targeted inhibitor for choroidal neovascularization in age-related macular degeneration.
Li W; Dong L; Ma M; Hu B; Lu Z; Liu X; Liu J; Li X
Drug Des Devel Ther; 2016; 10():3415-3423. PubMed ID: 27799741
[TBL] [Abstract][Full Text] [Related]
14. Amount of Mononuclear Phagocyte Infiltrate Does Not Predict Area of Experimental Choroidal Neovascularization (CNV).
Will-Orrego A; Qiu Y; Fassbender ES; Shen S; Aranda J; Kotagiri N; Maker M; Liao SM; Jaffee BD; Poor SH
J Ocul Pharmacol Ther; 2018 Sep; 34(7):489-499. PubMed ID: 30188257
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of RACK1 ameliorates choroidal neovascularization formation in vitro and in vivo.
Liu X; Zhu M; Yang X; Wang Y; Qin B; Cui C; Chen H; Sang A
Exp Mol Pathol; 2016 Jun; 100(3):451-9. PubMed ID: 27112838
[TBL] [Abstract][Full Text] [Related]
16. Correlation of CD105 and vascular endothelial growth factor in laser-induced choroidal neovascularization in rats.
Xu J; Wang Y; Yang X; Zhang P; Chen L
Yan Ke Xue Bao; 2006 Sep; 22(3):166-74, 183. PubMed ID: 17162902
[TBL] [Abstract][Full Text] [Related]
17. Targeting Platelet-Derived Growth Factor Receptor β(+) Scaffold Formation Inhibits Choroidal Neovascularization.
Strittmatter K; Pomeroy H; Marneros AG
Am J Pathol; 2016 Jul; 186(7):1890-9. PubMed ID: 27338108
[TBL] [Abstract][Full Text] [Related]
18. A Sema3C Mutant Resistant to Cleavage by Furin (FR-Sema3C) Inhibits Choroidal Neovascularization.
Toledano S; Lu H; Palacio A; Ziv K; Kessler O; Schaal S; Neufeld G; Barak Y
PLoS One; 2016; 11(12):e0168122. PubMed ID: 28036336
[TBL] [Abstract][Full Text] [Related]
19. miRNA involvement in angiogenesis in age-related macular degeneration.
Wang L; Lee AY; Wigg JP; Peshavariya H; Liu P; Zhang H
J Physiol Biochem; 2016 Dec; 72(4):583-592. PubMed ID: 27349759
[TBL] [Abstract][Full Text] [Related]
20. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
